Non - GAAP Measures
Search documents
Pitney Bowes(PBI) - 2025 Q4 - Earnings Call Presentation
2026-02-18 13:00
Pitney Bowes Fourth Quarter Earnings February 17, 2026 Forward-Looking Statements and Financial Presentation This document contains "forward-looking statements" about the Company's expected or potential future business and financial performance, including, but not limited to, statements about future revenue and profitability, earnings guidance, future events or conditions, capital allocation strategy, expected cost savings and efficiency improvements, and strategic initiatives and priorities. Forward-lookin ...
Allegion(ALLE) - 2025 Q4 - Earnings Call Presentation
2026-02-17 13:00
Q4-2025 Earnings Call February 17, 2026 Cautionary Statements Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are statements that are not historical facts, including, but not limited to, statements related to FY-2026 Outlook, FY-2026 EPS Outlook Details and statements regarding market trends, ele ...
Unitil(UTL) - 2025 Q4 - Earnings Call Presentation
2026-02-10 19:00
Q4 2025 Financial Results and Strategic Update February 10, 2026 Forward-Looking Statements and Use of Non-GAAP Measures This presentation contains "forward-looking statements" including within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included in this presentation are forward-looking statements. These forward-looking statements include statements regarding Unitil Corporation and its subsidiari ...
DLH(DLHC) - 2026 Q1 - Earnings Call Presentation
2026-02-10 15:00
February 10, 2026 CALL PARTICIPANTS FY26 First Quarter Earnings Three Months Ended 12.31.25 ZACH PARKER President & Chief Executive Officer KATHRYN JOHNBULL © Copyright 2026 DLH Holdings Corp. All Rights Reserved. 2 Forward-Looking Statements "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s f ...
Saputo Reports Financial Results for the Third Quarter of Fiscal 2026 Ended December 31, 2025
Globenewswire· 2026-02-05 22:00
Core Insights - Saputo Inc. reported strong financial results for Q3 of fiscal 2026, highlighting robust cash generation and margin expansion driven by operational efficiencies and strong demand for high-protein dairy products [2][3]. Financial Performance - Revenues for Q3 2026 were $4.888 billion, a decrease of $106 million or 2.1% compared to Q3 2025, primarily due to lower US dairy commodity market pricing [3][9]. - Adjusted EBITDA increased by 18.0% to $492 million, with an adjusted EBITDA margin of 10.1%, up from 8.4% [3][9]. - Net earnings reached $220 million, a significant increase from a loss of $518 million in the same quarter last year, with earnings per share (EPS) of $0.54 (basic) and $0.53 (diluted) [9][3]. Sector Performance Canada Sector - Revenues for Q3 2026 were $1.416 billion, up $57 million or 4.2% from Q3 2025, driven by higher sales volumes in retail, foodservice, and industrial segments [22][23]. - Adjusted EBITDA for Q3 2026 was $189 million, an increase of 8.0% from $175 million in Q3 2025, with an adjusted EBITDA margin of 13.3% [26][27]. USA Sector - Revenues for Q3 2026 totaled $2.142 billion, down $163 million or 7.1% compared to Q3 2025, impacted by lower US dairy commodity market pricing [32][33]. - Adjusted EBITDA increased by 15.6% to $185 million, with an adjusted EBITDA margin of 8.6%, up from 6.9% [36][37]. International and Europe Sectors - International Sector revenues for Q3 2026 were $994 million, down 2.5% from $1.019 billion in Q3 2025, while adjusted EBITDA rose by 60.8% to $82 million [47][53]. - Europe Sector revenues increased by 8.0% to $336 million, with adjusted EBITDA up 16.1% to $36 million [63][68]. Strategic Initiatives - The company is focused on optimizing its product mix and enhancing operational efficiencies through strategic investments in automation and cost-effective production capabilities [3][38]. - Continued investments in advertising and promotional activities are expected to support commercial growth across all sectors [3][41]. Future Outlook - The company anticipates organic sales growth, particularly in the USA Sector, supported by sustained growth in key retail categories and ongoing innovation [80]. - The International Sector is expected to benefit from improved economic conditions in Argentina and cost reductions in Australia, while the Europe Sector is projected to deliver improved performance through margin recovery and disciplined pricing [80].
Equitable(EQH) - 2025 Q4 - Earnings Call Transcript
2026-02-05 16:00
Financial Data and Key Metrics Changes - Full-year non-GAAP operating earnings were $5.64 per share, up 1% from 2024, with notable items adjusted EPS at $6.21 [5][6] - Full-year organic cash generation was $1.6 billion, consistent with guidance, expected to increase to approximately $1.8 billion in 2026 [6][12] - Assets under management and administration reached a record $1.1 trillion, up 10% year-over-year [6][17] - The company returned $1.8 billion to shareholders in 2025, with a payout ratio of 68% excluding incremental buybacks [6][22] Business Line Data and Key Metrics Changes - Retirement segment net flows were $5.9 billion in 2025, reflecting a 4% organic growth rate, supported by record RILA sales [7][11] - Wealth Management saw net inflows of $8.4 billion, achieving a 13% organic growth rate, with a 40% year-over-year increase in fourth-quarter earnings [7][20] - AllianceBernstein (AB) reported overall net outflows of $11.3 billion, but private markets business AUM increased by 18% to $82 billion [8][9] Market Data and Key Metrics Changes - The company experienced strong momentum in the private markets business, with a target of $90 billion-$100 billion in AUM by the end of 2027 [9] - The retirement business is expected to see mid to high single-digit growth in pre-tax earnings, with spreads stabilizing in the second half of 2026 [26][70] Company Strategy and Development Direction - The company is focused on three core growth engines: U.S. retirement, asset management, and wealth management, aiming to reshape its balance sheet to be more capital light [4][10] - The life reinsurance transaction with RGA is expected to create a more valuable company by freeing up $2 billion of capital and reducing mortality exposure by 75% [10][14] - The company aims to achieve $2 billion in annual cash generation by 2027, with a strong focus on organic growth and maintaining a disciplined approach to expenses [12][66] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 2027 financial targets, citing solid momentum entering 2026 and reduced mortality exposure [5][28] - The company anticipates EPS growth to accelerate in 2026, driven by strong cash generation and reduced volatility from mortality claims [13][14] - Management highlighted the importance of maintaining a disciplined approach to investments and capital returns while focusing on growth opportunities in attractive markets [88] Other Important Information - The adjusted book value per share was reported at $33.84, providing a more meaningful valuation than reported book value [18] - The company achieved a 33.7% adjusted operating margin at AB, indicating strong execution on margin initiatives [12] Q&A Session Summary Question: Insights on private credit portfolio quality - Management indicated that private credit constitutes about 16% of the total general account, with minimal exposure to software-related risks [32][34] Question: Competition for advisors in wealth management - The company reported a 12% growth in wealth planners, emphasizing a disciplined approach to hiring and targeting specific advisor practices [36][39] Question: Addressing the valuation gap between AB and Equitable - Management acknowledged the valuation gap and emphasized the focus on growing the business and improving execution to close this gap [42][45] Question: Mortality exposure and potential further reductions - Management discussed the impact of recent mortality claims and the prudent guidance for future mortality assumptions, indicating manageable volatility [46][48] Question: Commission and distribution expenses in retirement segment - Management explained the increase in commission expenses and the expectation of earnings growth exceeding commission expenses over time [53][54] Question: Growth potential of the FABN program - The company expressed optimism about growing the FABN program, which has shown attractive IRRs and contributes to retirement earnings [60][61] Question: Cash flow conversion and underlying drivers - Management confirmed improving cash conversion rates, driven by higher asset and wealth earnings and capital release from legacy blocks [64][66] Question: Competitive dynamics in the RILA market - Management noted the growing demand for RILAs and the company's commitment to maintaining disciplined pricing and strong IRRs despite increased competition [79][81]
Boston Scientific(BSX) - 2025 Q4 - Earnings Call Presentation
2026-02-04 13:00
Q4 2025 Highlights February 4, 2026 1 Q4 2025 Financial & Operational Highlights | February 4, 2026 Forward-Looking Statements and Use of Document Forward-looking statements: FCF is a non-GAAP measure calculated as operating cash flows less net purchases of property, plant, and equipment and internal use software. FCF Conversion is a non-GAAP measure calculated as FCF divided by adjusted net income available to common stockholders. Emerging Markets: Our Emerging Markets countries include all countries excep ...
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results
Prnewswire· 2026-02-04 12:00
NASDAQ | TSX: ACB EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025. 11 1 "Aurora has established a commanding leadership position within the rapidly expanding, high margin, global medical cannabis market. We achieved record quarterly net revenue of $76.2 million in our globa ...
Spire(SR) - 2026 Q1 - Earnings Call Presentation
2026-02-03 16:00
First quarter fiscal 2026 update February 3, 2026 Forward-looking statements and use of non-GAAP measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements in this presentation speak only as of today, and we assume no duty to update them. Forward- looking statements are typically identified by words such as, but not limited to: "estimates," "expects," "anticipates," "intends," "targets," "plans," " ...
Arthur J. Gallagher & Co. Announces Fourth Quarter and Full Year 2025 Financial Results
Prnewswire· 2026-01-29 21:15
Core Insights - Arthur J. Gallagher & Co. reported strong financial results for Q4 2025, with a revenue growth exceeding 30% in its combined Brokerage and Risk Management segments, marking the 20th consecutive quarter of double-digit growth [4][5] - The company achieved a total revenue of $3.586 billion for Q4 2025, compared to $2.679 billion in Q4 2024, reflecting a significant year-over-year increase [2][6] - For the full year 2025, Gallagher reported a revenue growth of 21%, with adjusted EBITDAC increasing by 26% [5][6] Financial Performance - Q4 2025 revenues before reimbursements reached $3.586 billion, up from $2.679 billion in Q4 2024, while net earnings were reported at $317 million, consistent with Q4 2024 [2][6] - The adjusted EBITDAC margin for Q4 2025 was 30.8%, with adjusted EBITDAC growing by 30% year-over-year [4][21] - The company completed 33 mergers in 2025, contributing to an estimated annualized revenue of over $3.5 billion [5][12] Segment Analysis - The Brokerage segment reported revenues of $3.169 billion in Q4 2025, compared to $2.296 billion in Q4 2024, with net earnings of $317 million [2][4] - The Risk Management segment generated $417 million in revenues for Q4 2025, up from $369 million in Q4 2024, maintaining a net earnings margin of 11.7% [2][6] - The Corporate segment reported a loss of $212 million in Q4 2025, reflecting increased transaction-related costs and legal expenses [2][6] Acquisition Activity - Gallagher's acquisition of AssuredPartners for approximately $13.8 billion was financed through a combination of cash raised from a stock offering and senior notes issuance [12] - In Q4 2025, Gallagher closed 6 acquisitions, with an estimated annualized revenue of $118 million from these transactions [10][12] Organic Growth - Organic revenue growth for the company was reported at 6% for the full year 2025, with a 5% organic growth in Q4 2025 [5][9] - The organic change in base commissions and fees for Q4 2025 was 4%, while supplemental revenues saw a 12% organic increase [9][10] Compensation and Operating Expenses - The reported compensation expense for Q4 2025 was $1.868 billion, with an adjusted compensation expense of $1.668 billion [13][25] - The operating expense ratio for Q4 2025 was reported at 16.6%, reflecting an increase from 15.0% in Q4 2024, primarily due to higher integration and technology costs [16][29]